Emerging evidence suggests that blood-oxygen-level-dependent signals in white matter reflect functional activity; however, it remains unclear whether white matter function is altered in rhegmatogenous retinal detachment (RRD) and how it interacts with gray matter. We conducted resting-state functional MRI analyses in patients with RRD and healthy controls to investigate regional white matter activity using amplitude of low-frequency fluctuations/fractional ALFF (ALFF/fALFF), and cross-tissue white matter-gray matter functional connectivity. Voxel-wise analyses were performed to identify aberrant white matter regions, and seed-based connectivity mapping was applied using affected white matter tracts. Support vector machine models were constructed to evaluate the diagnostic utility of these functional features. Patients with RRD exhibited significantly increased ALFF/fALFF in key projection fibers, including the bilateral anterior corona radiata (ACR) and anterior limb of the internal capsule (ALIC). Enhanced functional connectivity was observed between the left ACR and nonvisual gray matter regions such as the right middle temporal gyrus and medial orbitofrontal cortex. Among all features, the fALFF value of the left ALIC demonstrated the highest classification performance (area under the curve = 0.8974) in distinguishing RRD from healthy controls. These findings reveal aberrant spontaneous low-frequency oscillatory activity and enhanced white matter-gray matter coupling in patients with RRD, reflecting cross-tissue functional reorganization beyond the retina. Notably, the elevated fALFF signal in the left ALIC demonstrates strong potential as a neuroimaging biomarker. This study underscores the value of white matter functional metrics in characterizing central nervous system alterations in RRD and offers novel insights into its neurobiological underpinnings.

This review highlights recent advancements and evidence-based approaches in the critical care management of aneurysmal subarachnoid hemorrhage (aSAH), focusing on developments from the past 18 months. It addresses key challenges [rebleeding prevention, delayed cerebral ischemia (DCI), hydrocephalus, transfusion strategies, and temperature management], emphasizing multidisciplinary care and personalized treatment. Recent studies underscore the importance of systolic blood pressure control (<160 mmHg) to reduce rebleeding risk before aneurysm securing. Novel prognostic tools, including the modified 5-item frailty index and quantitative imaging software, show promise in improving outcome prediction. Prophylactic lumbar drainage may reduce DCI and improve neurological outcomes, while milrinone and computed tomography perfusion-guided therapies are being explored for vasospasm management. Transfusion strategies suggest a hemoglobin threshold of 9 g/dl may optimize outcomes. Temperature management remains contentious, but consensus recommends maintaining normothermia (36.0-37.5 °C) with continuous monitoring. Advances in aSAH care emphasize precision medicine, leveraging technology [e.g. Artificial intelligence (AI), quantitative imaging], and multidisciplinary collaboration. Key unresolved questions warrant multicenter trials to validate optimal blood pressure, transfusion, and temperature targets alongside emerging therapies for DCI.

Magnetic resonance imaging (MRI) offers multiple sequences that provide complementary views of brain anatomy and pathology. However, real-world datasets often exhibit variability in sequence availability due to clinical and logistical constraints. This variability complicates radiological interpretation and limits the generalizability of machine learning models that depend on a consistent multimodal input. Here, we propose an anatomy-guided, modality-agnostic framework to assess disease-related abnormalities in brain MRI, leveraging structural context to ensure robustness in diverse input configurations. Central to our approach is Region ModalMix (RMM), an augmentation strategy that integrates anatomical priors during training to improve model performance under missing or variable modality conditions. Using the BraTS 2020 dataset (n = 369), our framework outperformed state-of-the-art methods, achieving a 9.68 mm average reduction in 95th percentile Hausdorff Distance (HD95) and a 1.36 percentage point improvement in Dice Similarity Coefficient (DSC) over baselines with only one available modality. To evaluate out-of-distribution generalization, we tested RMM on the MU-Glioma-Post dataset (n = 593), which includes heterogeneous post-operative glioma cases. Despite distribution shifts, RMM maintained strong performance, reducing HD95 by 18.24 mm and improving DSC by 9.54% points in the most severe missing-modality scenario. Our framework is applicable to multimodal neuroimaging pipelines, enabling more generalizable abnormality detection under heterogeneous data availability.

This study aimed to design a web-based application for computer-aided diagnosis (CADx) of intraosseous jaw lesions, and assess its diagnostic accuracy. In this diagnostic test study, a web-based application was designed for CADx of 19 types of intraosseous jaw lesions. To assess its diagnostic accuracy, clinical and radiographic information of 95 cases with confirmed histopathological diagnosis of intraosseous jaw lesions were retrieved from hospital archives and published literature and imported to the application by a senior dental student. The top-N accuracy, kappa value, and Brier score were calculated, and the sensitivity, specificity, positive (PPV) and negative (NPV) predictive values, and the area under the receiver operating characteristic (ROC) curve (AUC) were calculated separately for each lesion according to DeLong et al. In assessment of top-N accuracy, the designed application gave a correct differential diagnosis in 93 cases (97.89%); the correct diagnosis was at the top of the list of differential diagnoses in 78 cases (82.10%); these values were 85 (89.47%) and 67 (70.52%) for an oral radiologist. The kappa value was 0.53. The Brayer score for the prevalence match was 0.18, and the pattern match was 0.15. The results highlighted the optimally high diagnostic accuracy of the designed application, indicating that it may be reliably used for CADx of intraosseous jaw lesions, if given accurate data.

Predictive tools for stratifying neonatal hydrocephalus into low- and high-risk groups for cerebrospinal fluid (CSF) diversion are currently lacking. We developed and validated an artificial intelligence (AI) model that integrates multimodal imaging and clinical data to predict CSF diversion needs. The development cohort included 116 neonates with suspicion of raised intracranial pressure (ICP) from a Chinese tertiary referral hospital (80 with intracranial pressure > 80 mm H₂O, 36 with intracranial pressure ≤ 80 mm H₂O). The external validation cohort consisted of 21 neonates with hydrocephalus from an American medical center, categorized by etiology: prenatal myelomeningocele (MMC) closure (n = 5), postnatal MMC closure (n = 6), and post-hemorrhagic hydrocephalus (PHH) (n = 10). Inclusion criteria required available MRI and complete clinical follow-up to confirm CSF diversion outcomes. The primary outcome was the need for CSF diversion. Model performance was assessed using under the receiver operating characteristics curve (AUC), sensitivity, and specificity. The hybrid AI model achieved an AUC of 0.824 in the development cohort in predicting raised ICP, outperforming both the clinical-only model (AUC 0.528, p < 0.001) and the image-only model (AUC 0.685, p = 0.007). In the external validation cohort, the fused MRI-based model achieved an AUC of 0.808. The model correctly predicted CSF diversion in 4/5 prenatal MMC, 4/6 postnatal MMC, and 9/10 PHH cases. The AI model demonstrated robust performance in predicting the need for CSF diversion, particularly in PHH cases, and has the potential to assist decision-making, especially in settings with limited pediatric neurosurgical expertise. Future work should focus on further refining model performance for complex etiologies such as MMC-associated hydrocephalus.

Neurodegeneration occurs when the body's central nervous system becomes impaired as a person ages, which can happen at an accelerated pace. Neurodegeneration impairs quality of life, affecting essential functions, including memory and the ability to self-care. Genetics play an important role in neurodegeneration and longevity. Brain age gap estimation (BrainAGE) is a biomarker that quantifies the difference between a machine learning model-predicted biological age of the brain and the true chronological age for healthy subjects; however, a large portion of the variance remains unaccounted for in these models, attributed to individual differences. This study focuses on predicting the BrainAGE more accurately, aided by genetic information associated with neurodegeneration. To achieve this, a BrainAGE model was developed based on MRI measures, and then the associated genes were determined with a Genome-Wide Association Study. Subsequently, genetic information was incorporated into the models. The incorporation of genetic information yielded improvements in the model performances by 7% to 12%, showing that the incorporation of genetic information can notably reduce unexplained variance. This work helps to define new ways of determining persons susceptible to neurological aging decline and reveals genes for targeted precision medicine therapies.

Misregistration between CT and PET can result in mis-localization and inaccurate quantification of the tracer uptake in PET. Data-driven gated (DDG) CT can correct registration and quantification but requires a radiation dose of 1.3 mSv and 1 min of acquisition time. AI registration (AIR) does not require an additional CT and has been validated to improve registration and reduce the 'banana' misregistration artifacts around the diaphragm. We aimed to compare a validated AIR and DDG CT in registration and quantification of avid thoracic lesions misregistered in DDG PET scans. Thirty PET/CT patient data (23 with ¹⁸F-FDG, 4 with ⁶⁸Ga-Dotatate, and 3 with ¹⁸F-PSMA piflufolastat) with at least one misregistered avid lesion in the thorax were recruited. Patient studies were conducted using DDG CT to correct misregistration with DDG PET data of the phases 30 to 80% on GE Discovery MI PET/CT scanners. Non-attenuation correction DDG PET and misregistered CT were input to AIR and the AIR-corrected CT data were output to register and quantify the DDG PET data. Registration and quantification of lesion SUV_max and signal-to-background ratio (SBR) of the lesion SUV_max to the 2-cm background mean SUV were compared for each of the 51 avid lesions. DDG CT outperformed AIR in misregistration correction and quantification of avid thoracic lesions (1.16 ± 0.45 cm). Most lesions (46/51, 90%) showed improved registration from DDG CT relative to AIR, with 10% (5/51) being similar between AIR and DDG CT. The lesions in the baseline CT were an average of 2.06 ± 1.0 cm from their corresponding lesions in the DDG CT, while those in the AIR CT were an average of 0.97 ± 0.54 cm away. AIR significantly improved lesion registration compared to the baseline CT (P < 0.0001). SUV_max increased by 18.1 ± 15.3% with AIR, but a statistically significantly larger increase of 34.4 ± 25.4% was observed with DDG CT (P < 0.0001). A statistically significant increase in SBR was also observed, rising from 10.5 ± 12.1% of AIR to 21.1 ± 20.5% of DDG CT (P < 0.0001). Many registration improvements by AIR were still left with misregistration. AIR could mis-localize a lymph node to the lung parenchyma or the ribs, and could also mis-localize a lung nodule to the left atrium. AIR could also distort the rib cage and the circular shape of the aorta cross section. DDG CT outperformed AIR in both localization and quantification of the thoracic avid lesions. AIR improved registration of the misregistered PET/CT. Registered lymph nodes could be falsely misregistered by AIR. AIR-induced distortion of the rib cage can also negatively impact image quality. Further research on AIR's accuracy in modeling true patient respiratory motion without introducing new misregistration or anatomical distortion is warranted.

Vision-threatening eye diseases pose a major global health burden, with timely diagnosis limited by workforce shortages and restricted access to specialized care. While multimodal large language models (MLLMs) show promise for medical image interpretation, advancing MLLMs for ophthalmology is hindered by the lack of comprehensive benchmark datasets suitable for evaluating generative models. We present a large-scale multimodal ophthalmology benchmark comprising 32,633 instances with multi-granular annotations across 12 common ophthalmic conditions and 5 imaging modalities. The dataset integrates imaging, anatomical structures, demographics, and free-text annotations, supporting anatomical structure recognition, disease screening, disease staging, and demographic prediction for bias evaluation. This work extends our preliminary LMOD benchmark with three major enhancements: (1) nearly 50% dataset expansion with substantial enlargement of color fundus photography; (2) broadened task coverage including binary disease diagnosis, multi-class diagnosis, severity classification with international grading standards, and demographic prediction; and (3) systematic evaluation of 24 state-of-the-art MLLMs. Our evaluations reveal both promise and limitations. Top-performing models achieved ~58% accuracy in disease screening under zero-shot settings, and performance remained suboptimal for challenging tasks like disease staging. We will publicly release the dataset, curation pipeline, and leaderboard to potentially advance ophthalmic AI applications and reduce the global burden of vision-threatening diseases.

Current measures of adiposity have limitations. Artificial intelligence (AI) models may accurately and efficiently estimate body composition (BC) from routine imaging. To assess the association of AI-derived BC compartments from magnetic resonance imaging (MRI) with cardiometabolic outcomes. Prospective cohort study. UK Biobank (UKB) observational cohort study. 33 432 UKB participants with no history of diabetes, myocardial infarction, or ischemic stroke (mean age, 65.0 years [SD, 7.8]; mean body mass index [BMI], 25.8 kg/m² [SD, 4.2]; 52.8% female) who underwent whole-body MRI. An AI tool was applied to MRI to derive 3-dimensional (3D) BC measures, including subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT), skeletal muscle (SM), and SM fat fraction (SMFF), and then calculate their relative distribution. Sex-stratified associations of these relative compartments with incident diabetes mellitus (DM) and major adverse cardiovascular events (MACE) were assessed using restricted cubic splines. Adipose tissue compartments and SMFF increased and SM decreased with age. After adjustment for age, smoking, and hypertension, greater adiposity and lower SM proportion were associated with higher incidence of DM and MACE after a median follow-up of 4.2 years in sex-stratified analyses; however, after additional adjustment for BMI and waist circumference (WC), only elevated VAT proportions and high SMFF (top fifth percentile in the cohort for each) were associated with increased risk for DM (respective adjusted hazard ratios [aHRs], 2.16 [95% CI, 1.59 to 2.94] and 1.27 [CI, 0.89 to 1.80] in females and 1.84 [CI, 1.48 to 2.27] and 1.84 [CI, 1.43 to 2.37] in males) and MACE (1.37 [CI, 1.00 to 1.88] and 1.72 [CI, 1.23 to 2.41] in females and 1.22 [CI, 0.99 to 1.50] and 1.25 [CI, 0.98 to 1.60] in males). In addition, in males only, those in the bottom fifth percentile of SM proportion had increased risk for DM (aHR for the bottom fifth percentile of the cohort, 1.96 [CI, 1.45 to 2.65]) and MACE (aHR, 1.55 [CI, 1.15 to 2.09]). Results may not be generalizable to non-Whites or people outside the United Kingdom. Artificial intelligence-derived BC proportions were strongly associated with cardiometabolic risk, but after BMI and WC were accounted for, only VAT proportion and SMFF (both sexes) and SM proportion (males only) added prognostic information. None.

Medical Image plays a vital role in diagnosis, but noise in patient scans severely affects the accuracy and quality of images. Denoising methods are important to increase the clarity of these images, particularly in low-resource settings where current diagnostic roles are inaccessible. Pneumonia is a widespread disease that presents significant diagnostic challenges due to the high similarity between its various types and the lack of medical images for emerging variants. This study introduces a novel Diffusion with swin transformer-based Optimized Crow Search algorithm to increase the image's quality and reliability. This technique utilizes four datasets such as brain tumor MRI dataset, chest X-ray image, chest CT-scan image, and BUSI. The preprocessing steps involve conversion to grayscale, resizing, and normalization to improve image quality in medical image (MI) datasets. Gaussian noise is introduced to further enhance image quality. The method incorporates a diffusion process, swin transformer networks, and optimized crow search algorithm to improve the denoising of medical images. The diffusion process reduces noise by iteratively refining images while swin transformer captures complex image features that help differentiate between noise and essential diagnostic information. The crow search optimization algorithm fine-tunes the hyperparameters, which minimizes the fitness function for optimal denoising performance. The method is tested across four datasets, indicating its optimal effectiveness against other techniques. The proposed method achieves a peak signal-to-noise ratio of 38.47 dB, a structural similarity index measure of 98.14%, a mean squared error of 0.55, and a feature similarity index measure of 0.980, which outperforms existing techniques. These outcomes reflect that the proposed approach effectively enhances the quality of images, resulting in precise and dependable diagnoses.